Drug Trial Radar · NCT06767683
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
786
Planned (sponsor's estimate)
Start
Jan 27, 2025
Primary completion
Jun 2030
Study completion Jun 2030
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to continue to measure the safety, tolerability, and durability of treatment effect in subjects with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypersomnia (IH) when taking ALKS 2680 tablets.
Conditions
- Narcolepsy Type 1
- Narcolepsy Type 2
- Idiopathic Hypersomnia
Interventions
ALKS 2680, 4mgDrug
Oral tablet containing 4 mg of ALKS 2680 for once daily administration
ALKS 2680, 6mgDrug
Oral tablet containing 6 mg of ALKS 2680 for once daily administration
ALKS 2680, 8mgDrug
Oral tablet containing 8 mg of ALKS 2680 for once daily administration
ALKS 2680, 10mgDrug
Oral tablet containing 10 mg of ALKS 2680 for once daily administration
ALKS 2680, 14mgDrug
Oral tablet containing 14 mg of ALKS 2680 for once daily administration
ALKS 2680, 18mgDrug
Oral tablet containing 18 mg of ALKS 2680 for once daily administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse EventsTime frame: Up to 248 Weeks
Locations
50 sites in 8 countries. Site status is shown where the registry gives one.
Alkermes Investigational Site
Cullman, Alabama · Recruiting
Alkermes Investigator Site
Phoenix, Arizona · Recruiting
Alkermes Investigational Site
Little Rock, Arkansas · Recruiting
Alkermes Investigational Site
Los Angeles, California · Recruiting
Alkermes Investigator Site
San Francisco, California · Recruiting
Alkermes Investigational Site
Stanford, California · Recruiting
Alkermes Investigational Site
Boulder, Colorado · Recruiting
Alkermes Investigational Site
Colorado Springs, Colorado · Recruiting
Alkermes Investigational Site
Brandon, Florida · Recruiting
Alkermes Investigational Site
Miami, Florida · Recruiting
Alkermes Investigational Site
Winter Park, Florida · Recruiting
Alkermes Investigational Site
Atlanta, Georgia · Recruiting
Alkermes Investigational Site
Macon, Georgia · Recruiting
Alkermes Investigational Site
Stockbridge, Georgia · Recruiting
Alkermes Investigational Site
Peoria, Illinois · Recruiting
Alkermes Investigational Site
Kansas City, Kansas · Recruiting
Alkermes Investigational Site
Lansing, Michigan · Recruiting
Alkermes Investigational Site
Sterling Heights, Michigan · Recruiting
Alkermes Investigational Site
Lincoln, Nebraska · Recruiting
Alkermes Investigational Site
Middletown, New Jersey · Terminated
Alkermes Investigational Site
Denver, North Carolina · Recruiting
Alkermes Investigational Site
Huntersville, North Carolina · Recruiting
Alkermes Investigational Site
Canton, Ohio · Recruiting
Alkermes Investigational Site
Cincinnati, Ohio · Recruiting
Alkermes Investigational Site
Cincinnati, Ohio · Recruiting
Alkermes Investigational Site
Dublin, Ohio · Recruiting
Alkermes Investigational Site
Abington, Pennsylvania · Recruiting
Alkermes Investigational Site
Wyomissing, Pennsylvania · Recruiting
Alkermes Investigational Site
Columbia, South Carolina · Recruiting
Alkermes Investigational Site
Austin, Texas · Recruiting
Alkermes Investigational Site
Dallas, Texas · Recruiting
Alkermes Investigational Site
San Antonio, Texas · Recruiting
Alkermes Investigational Site
Sugar Land, Texas · Recruiting
Alkermes Investigational Site
Madison, Wisconsin · Recruiting
Alkermes Investigational Site
Sydney, New South Wales, Australia · Recruiting
Alkermes Investigational Site
Bedford Park, South Australia, Australia · Recruiting
Alkermes Investigational Site
Clayton, Victoria, Australia · Recruiting
Alkermes Investigational Site
Alken, Belgium · Recruiting
Alkermes Investigational Site
Namur, Belgium · Recruiting
Alkermes Investigational Site
Bruges, Brugge, Belgium · Recruiting
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.